Sarepta to seek new CEO as Exondys 51 tops guidance

Sarepta Therapeutics Inc. (NASDAQ:SRPT) President and CEO Edward Kaye said he intends to resign at the end of his employment term, but remain on the company's board. His employment term ends Sept. 20, according to a regulatory filing.

On a conference call Thursday, Kaye said the transition will allow the incoming CEO to focus on the company's commercial strategy, while he would continue to work on scientific and regulatory issues as a board member...